• Carolyn Maloney

LAWMAKERS SEEK CLARITY FROM GAO ON REMDESIVIR

Sen. Debbie Stabenow (D-Mich.) and House Oversight Chair Carolyn Maloney (D-N.Y.) are asking the GAO to look into how much the federal government spent and contributed to the development of Gilead’s Covid-19 drug remdesivir, POLITICO's Zachary Brennan reports.


The letter continues the work of the late Elijah Cummings, who as Oversight chair worked with Stabenow to investigate the patents behind Gilead’s HIV drug Truvada. The effort led to HHS suing Gilead over patent infringement last November.


Read more.

6 views

©2019